Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – Interest in making it a therapeutic target
Author:
Funder
Fonds Wetenschappelijk Onderzoek
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference233 articles.
1. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel;Aghajani;Molecular Biology Reports,2020
2. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies;Angara;Histology and Histopathology,2017
3. Vascular mimicry: The next big glioblastoma target;Arbab;Biochemistry & Physiology,2015
4. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells;Atzori;Journal of Experimental & Clinical Cancer Research : CR,2017
5. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals;Bai;Oncogene,2018
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. VEGF signaling: Role in angiogenesis and beyond;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03
2. Engineered in vivo and in vitro tumor model recapitulates vasculogenic mimicry signatures in melanoma;Bioengineering & Translational Medicine;2024-01-27
3. Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma;Theranostics;2024
4. RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment;Journal for ImmunoTherapy of Cancer;2024-01
5. The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features;Frontiers in Pharmacology;2023-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3